BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25030920)

  • 1. Cancer metabolism: cross talk between signaling and O-GlcNAcylation.
    Ferrer CM; Reginato MJ
    Methods Mol Biol; 2014; 1176():73-88. PubMed ID: 25030920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
    Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
    J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
    Hanover JA; Chen W; Bond MR
    J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
    Phillips RM; Lam C; Wang H; Tran PT
    Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
    Itano N; Iwamoto S
    Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.
    Ferrer CM; Lynch TP; Sodi VL; Falcone JN; Schwab LP; Peacock DL; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cell; 2014 Jun; 54(5):820-31. PubMed ID: 24857547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
    Akella NM; Ciraku L; Reginato MJ
    BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.
    Ferrer CM; Sodi VL; Reginato MJ
    J Mol Biol; 2016 Aug; 428(16):3282-3294. PubMed ID: 27343361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc signaling: a metabolic link between diabetes and cancer?
    Slawson C; Copeland RJ; Hart GW
    Trends Biochem Sci; 2010 Oct; 35(10):547-55. PubMed ID: 20466550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
    Love DC; Hanover JA
    Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cancer metabolism by O-GlcNAcylation.
    Li Z; Yi W
    Glycoconj J; 2014 Apr; 31(3):185-91. PubMed ID: 24323367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hexosamine biosynthesis pathway and O-GlcNAcylation maintain insulin-stimulated PI3K-PKB phosphorylation and tumour cell growth after short-term glucose deprivation.
    Jones DR; Keune WJ; Anderson KE; Stephens LR; Hawkins PT; Divecha N
    FEBS J; 2014 Aug; 281(16):3591-608. PubMed ID: 24938479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
    Nagel AK; Ball LE
    Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
    Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
    Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights: A role for O-GlcNAcylation in diabetic complications.
    Peterson SB; Hart GW
    Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 18.
    Zhang H; Qi J; Pei J; Zhang M; Shang Y; Li Z; Wang Y; Guo J; Sun K; Fan J; Sui L; Xu Y; Kong L; Kong Y
    J Adv Res; 2022 Mar; 37():119-131. PubMed ID: 35499042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAc signaling in cancer metabolism and epigenetics.
    Singh JP; Zhang K; Wu J; Yang X
    Cancer Lett; 2015 Jan; 356(2 Pt A):244-50. PubMed ID: 24769077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.
    Butkinaree C; Park K; Hart GW
    Biochim Biophys Acta; 2010 Feb; 1800(2):96-106. PubMed ID: 19647786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.